A Randomized, Double-blinded Placebo-controlled Clinical Trial of the Routine Use of Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy
- 912 Downloads
The effectiveness of antibiotic prophylaxis for prevention of surgical site infection (SSI) following specific types of breast cancer surgery remains uncertain. This study assessed the effectiveness of prophylaxis in modified radical mastectomy (MRM).
Women undergoing MRM for breast cancer were recruited. Women were excluded who had diabetes mellitus, severe malnutrition or known allergy to cephalosporins; were receiving corticosteroid therapy or were treated with antibiotics within one week prior to surgery; were scheduled for simultaneous breast reconstruction or bilateral oophorectomy; had existing local infection. Participants were randomized to receive either intravenous cefazolin 1 g or placebo within 30 min prior to skin incision. Standard skin preparation and operative technique for MRM were carried out. Wounds were assessed for SSI and other complications weekly for 30 days.
A total of 254 women were recruited. Age, clinical stage, prior chemotherapy, and operative time were similar for antibiotic and placebo groups. The overall incidence of SSI was 14.2 %. There were no significant differences in the infection rate over the 30-day follow-up period between the placebo and antibiotic groups (15 % vs 13.4 %; p = 0.719) or at each week. The majority of SSI were either cellulitis or superficial infection for both groups. There were no significant differences between groups in treatments required for SSI, incidence of hematoma or seroma.
The findings of this study, alone and when meta-analyzed with data from studies in similar surgical populations, do not support the use of antibiotic prophylaxis in MRM.
KeywordsAxillary Lymph Node Dissection Antibiotic Prophylaxis Necrotizing Fasciitis Modify Radical Mastectomy Antibiotic Group
The research on which this article is based was funded by grants from the Research Implementation and Development Office, College of Medicine, and the National Institutes of Health, University of the Philippines, Manila. The authors are grateful to Joy B. Sison for work as research assistant and Rheamel Lopez for help in collation and analysis of data. The article is registered with ClinicalTrials.gov at the National Library of Medicine, NIH (USA) under Registration No. NCT01558986. The National Institutes of Health (Philippines) Protocol No. is NIH 2007-07-10-02.
- 3.Bunn F, Jones DJ, Bell-Syer S (2012) Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database of Systematic Rev; 1, CD005360. doi: 10.1002/14651858.CD005360.pub3
- 4.Mallari-Cutungal MG, Codamos LJ, Coronel RF (1999) Antibiotic prophylaxis in elective breast surgery: a meta-analysis of randomized placebo-controlled trials. Philipp J Microbiol Infect Dis 28:154–158Google Scholar
- 8.Philippine College of Surgeons (2001) Evidence-based clinical practice guidelines for antibiotic prophylaxis in elective surgical procedures. PCS, ManilaGoogle Scholar
- 9.Scottish Intercollegiate Guidelines Network (2008) Antibiotic prophylaxis in surgery. A national clinical guideline. SIGN, EdinburghGoogle Scholar
- 10.National Collaborating Centre for Women’s Children’s health/national institute for health and clinical excellence (2008) Surgical site infection: prevention and treatment of surgical site infection. NICE, LondonGoogle Scholar
- 11.Western Australia Department of Health (2009) CPI Guide to surgical site infection prevention. Government of Western Australia Department of Health, PerthGoogle Scholar
- 12.Hong Kong Centre for Health Protection (2009) Recommendations on Prevention of Surgical Site Infection. Centre for Health Protection, Department of Health, Hong KongGoogle Scholar